These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Choosing an antibiotic on the basis of pharmacodynamics. Craig WA Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects. Levison ME Infect Dis Clin North Am; 1995 Sep; 9(3):483-95. PubMed ID: 7490429 [TBL] [Abstract][Full Text] [Related]
6. Once-daily versus multiple-daily dosing of aminoglycosides. Craig WA J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110 [TBL] [Abstract][Full Text] [Related]
7. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
8. Macrolides: pharmacokinetics and pharmacodynamics. Van Bambeke F; Tulkens PM Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of antimicrobial therapy in surgery. DiPiro JT; Edmiston CE; Bohnen JM Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Burgess DS Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455 [TBL] [Abstract][Full Text] [Related]
11. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies. Owens RC; Shorr AF Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S23-30. PubMed ID: 19502225 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance. Schentag JJ J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of antibacterial drugs. Levison ME Infect Dis Clin North Am; 2000 Jun; 14(2):281-91, vii. PubMed ID: 10829256 [TBL] [Abstract][Full Text] [Related]
14. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents. Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351 [TBL] [Abstract][Full Text] [Related]
15. Optimal adaptive control of pharmacodynamic effects with aminoglycoside antibiotics: a required approach for the future. Garraffo R Int J Biomed Comput; 1994 Jun; 36(1-2):43-57. PubMed ID: 7927859 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of subinhibitory antibiotic concentrations. Odenholt I Int J Antimicrob Agents; 2001 Jan; 17(1):1-8. PubMed ID: 11137642 [TBL] [Abstract][Full Text] [Related]
17. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA. Craig WA Eur J Clin Microbiol Infect Dis; 1995 Jul; 14(7):636-42. PubMed ID: 7588857 [TBL] [Abstract][Full Text] [Related]
19. The pharmacodynamics of aminoglycosides. Lacy MK; Nicolau DP; Nightingale CH; Quintiliani R Clin Infect Dis; 1998 Jul; 27(1):23-7. PubMed ID: 9675444 [TBL] [Abstract][Full Text] [Related]
20. Killing and regrowth of bacteria in vitro: a review. Craig WA; Ebert SC Scand J Infect Dis Suppl; 1990; 74():63-70. PubMed ID: 2097720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]